Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels

Clinical trial NCT06910098 · COMPLETED

Trial details

NCT number: NCT06910098
Sponsor: Central Park Medical College
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

LDL - Low Density Lipoprotein Receptor Disorder Rosuvastatin

Start date: 2023-12-01
Primary completion: 2024-06-30
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.